Format

Send to

Choose Destination
See comment in PubMed Commons below
Aging (Albany NY). 2010 Aug;2(8):527-34.

Controlling SIRT1 expression by microRNAs in health and metabolic disease.

Author information

1
Department of Molecular and Integrative Physiology, University of Illinois, Urbana-Champaign, IL 61801, USA.

Abstract

SIRT1 is a NAD+-dependent deacetylase implicated in longevity and diverse physiological processes. SIRT1, as a key mediator of beneficial effects of caloric restriction, regulates lipid and glucose metabolism by deacetylating metabolic regulators, as well as histones, in response to nutritional deprivation. Here we discuss how SIRT1 levels are regulated by microRNAs (miRs) which are emerging as important metabolic regulators; the recently identified nuclear receptor FXR/SHP cascade pathway that controls the expression of miR-34a and its target SIRT1; and a FXR/SIRT1 positive feedback regulatory loop, which is deregulated in metabolic disease states. The FXR/miR-34a pathway and other miRs controlling SIRT1 may be useful therapeutic targets for age-related diseases, including metabolic disorders.

PMID:
20689156
PMCID:
PMC2954045
DOI:
10.18632/aging.100184
[Indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Impact Journals, LLC Icon for PubMed Central
    Loading ...
    Support Center